These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

811 related articles for article (PubMed ID: 32100496)

  • 41. [Influence of electroacupuncture intervention on serum retinol binding protein 4 and liver function in nonalcoholic fatty liver rats].
    Zhu LL; Gou ZJ; Zeng ZH; Zhuo LS
    Zhen Ci Yan Jiu; 2012 Apr; 37(2):99-103. PubMed ID: 22764593
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Influence of electroacupuncture stimulation on serum and hepatic interleukin-18 expression in nonalcoholic fatty liver rats].
    Wang L; Gong B; Zhu LL; Zhuo LS; Li XZ; Zhang QS; Wu F
    Zhen Ci Yan Jiu; 2013 Jun; 38(3):208-13. PubMed ID: 24006666
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Effect of Electroacupunctrue Stimulation at "Fenglong"(ST 40) on Expression of SREBP-1 c in Non-alcoholic Fatty Liver Disease Rats].
    Yu M; Li G; Tang CL; Gao RQ; Feng QT; Cao J
    Zhen Ci Yan Jiu; 2017 Aug; 42(4):308-14. PubMed ID: 29072011
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Clinical therapeutic effect of hyperlipidemia of turbid phlegm obstruction pattern/syndrome treated with the different Jin's three-needle therapies].
    Li ZX; Xie YL; Yi W; Zhang HH; Tang XR; Liu XX; Xu NG
    Zhen Ci Yan Jiu; 2019 Dec; 44(12):916-21. PubMed ID: 31867913
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Effect of Low Glycemic Index and Glycemic Load Diets on Hepatic Fat Mass, Insulin Resistance, and Blood Lipid Panels in Individuals with Nonalcoholic Fatty Liver Disease.
    Parker A; Kim Y
    Metab Syndr Relat Disord; 2019 Oct; 17(8):389-396. PubMed ID: 31305201
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Effect of Nrf2 and related factors on the progression of nonalcoholic steatohepatitis].
    Cai YQ; Zhang LZ; Wang DJ; Chen FM; Chen ZY; Zhu KY; Li JS; Yan MX
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2014 Sep; 30(5):465-70. PubMed ID: 25571645
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Protective effect of probiotics in patients with non-alcoholic fatty liver disease.
    Cai GS; Su H; Zhang J
    Medicine (Baltimore); 2020 Aug; 99(32):e21464. PubMed ID: 32769877
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Risk Factor Analysis for Type 2 Diabetes Mellitus Patients with Nonalcoholic Fatty Liver Disease and Positive Correlation with Serum Uric Acid.
    Li YL; Xie H; Musha H; Xing Y; Mei CX; Wang HJ; Wulasihan M
    Cell Biochem Biophys; 2015 Jul; 72(3):643-7. PubMed ID: 27352181
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Predictors of non-alcoholic fatty liver disease in obese children.
    Sartorio A; Del Col A; Agosti F; Mazzilli G; Bellentani S; Tiribelli C; Bedogni G
    Eur J Clin Nutr; 2007 Jul; 61(7):877-83. PubMed ID: 17151586
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Impact of electro-acupuncture on lipid metalolism in rats with non-alcoholic fatty liver disease].
    Zhu LL; Wei WM; Zeng ZH; Zhuo LS
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Nov; 43(6):847-50. PubMed ID: 23387211
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Effects of lycopene on metabolism of glycolipid and inflammation in non-alcoholic fatty liver disease rats].
    Zhang P; Li J; Li M; Sui Y; Zhou Y; Sun Y
    Wei Sheng Yan Jiu; 2020 Mar; 49(2):254-271. PubMed ID: 32290942
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Acupuncture and Chinese medicine of artificial cycle therapy for insulin resistance of polycystic ovary syndrome with phlegm damp type and its mechanism].
    Yang J; Liu Y; Huang J; Xu J; You X; Lin Q; Zhang J; Dun J; Huang S
    Zhongguo Zhen Jiu; 2017 Nov; 37(11):1163-8. PubMed ID: 29354951
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Green cardamom supplementation improves serum irisin, glucose indices, and lipid profiles in overweight or obese non-alcoholic fatty liver disease patients: a double-blind randomized placebo-controlled clinical trial.
    Daneshi-Maskooni M; Keshavarz SA; Qorbani M; Mansouri S; Alavian SM; Badri-Fariman M; Jazayeri-Tehrani SA; Sotoudeh G
    BMC Complement Altern Med; 2019 Mar; 19(1):59. PubMed ID: 30871514
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gamma glutamyl transferase is an independent determinant for the association of insulin resistance with nonalcoholic fatty liver disease in Bangladeshi adults: Association of GGT and HOMA-IR with NAFLD.
    Hossain IA; Rahman Shah MM; Rahman MK; Ali L
    Diabetes Metab Syndr; 2016; 10(1 Suppl 1):S25-9. PubMed ID: 26482965
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Regulation effects of electroacupuncture with different acupoint combinations on blood lipid in rats with hyperlipemia].
    Zhang GX; Miao JL; Zhang ZY; Wang HJ; Ji LX
    Zhongguo Zhen Jiu; 2014 Sep; 34(9):894-7. PubMed ID: 25509744
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Mechanism of catgut embedding at back-
    Zhou XL; Tang N; Wu T; Zhang Y; Chen Q; Wei WH; Zhou YN; Zhang DX; Qin FC; Yang W
    Zhongguo Zhen Jiu; 2020 Jan; 40(1):59-66. PubMed ID: 31930901
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Electroacupuncture Attenuates Liver Inflammation in Nonalcoholic Fatty Liver Disease Rats.
    Ma B; Li P; An H; Song Z
    Inflammation; 2020 Dec; 43(6):2372-2378. PubMed ID: 32737656
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Correlation of Homocysteine, AHSG, CRP with Insulin Resistance, 25-(OH)2-VitD, Blood Lipids in Gestational Diabetes Patients.
    Jiang XC; Liang ZD; Chen DL; Jia JP; Hu JR; Hu L
    Clin Lab; 2021 Feb; 67(2):. PubMed ID: 33616345
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Influence of electroacupuncture on insulin-resistance in nonalcoholic fatty liver rats].
    Feng WQ; Zeng ZH; Zhuo LS
    Zhen Ci Yan Jiu; 2008 Apr; 33(2):111-5. PubMed ID: 18630587
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nano-curcumin improves glucose indices, lipids, inflammation, and Nesfatin in overweight and obese patients with non-alcoholic fatty liver disease (NAFLD): a double-blind randomized placebo-controlled clinical trial.
    Jazayeri-Tehrani SA; Rezayat SM; Mansouri S; Qorbani M; Alavian SM; Daneshi-Maskooni M; Hosseinzadeh-Attar MJ
    Nutr Metab (Lond); 2019; 16():8. PubMed ID: 30705687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.